As Regulatory Manager at AgomAb Therapeutics, Natalie De Jonge is responsible for the regulatory strategy of all compounds, including small molecules and antibodies. Natalie has previously worked at argenx from 2009 until 2022. She worked in various roles and departments starting as a scientist, transitioned to a management role overseeing the development of research or clinical assets and finally joined the regulatory department.